Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostaglandin E synthase 3 pseudogene 1 (PTGES3P1) is a non-functional genetic locus categorized as a pseudogene, situated at or near the prostaglandin E synthase 3 (PTGES3) gene region. Pseudogenes are segments of DNA resembling known genes but are typically non-coding and non-functional due to mutations that prevent transcription or translation into a functional protein. PTGES3P1 does not code for a receptor, enzyme, or any protein product implicated in disease mechanisms, and is not a subject of drug targeting or therapeutic intervention. There is no evidence that PTGES3P1 plays any regulatory or disease-related role, and the name may lead to confusion with actual drug targets such as PTGES3 (Prostaglandin E synthase 3), which encodes a functional protein involved in prostaglandin biosynthesis. If a therapeutic target is intended, users should refer to the parent gene "Prostaglandin E synthase 3" (PTGES3), not "Prostaglandin E synthase 3 pseudogene 1" (PTGES3P1), as the latter is not functionally relevant in drug discovery or disease pathology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin E synthase 3 pseudogene 1 (PTGES3P1).